메뉴 건너뛰기




Volumn 9, Issue 1, 2014, Pages

Patient-reported outcomes following stereotactic body radiation therapy for clinically localized prostate cancer

Author keywords

Bother; CyberKnife; EPIC; Function; Late symptom flare; Prostate cancer; SBRT

Indexed keywords

ADULT; AGED; AGED, 80 AND OVER; FOLLOW-UP STUDIES; HUMANS; INTESTINAL DISEASES; MALE; MIDDLE AGED; PATIENT OUTCOME ASSESSMENT; PROSTATIC NEOPLASMS; QUALITY OF LIFE; RADIATION INJURIES; RADIOSURGERY; SELF REPORT; SEXUAL BEHAVIOR; TREATMENT OUTCOME; URINATION;

EID: 84894350573     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-9-52     Document Type: Article
Times cited : (49)

References (32)
  • 1
    • 84889590915 scopus 로고    scopus 로고
    • Stereotactic body radiotherapy for localized prostate cancer: pooled analysis from a multi-institutional consortium of prospective phase II trials
    • 10.1016/j.radonc.2013.08.030, 24060175
    • King CR, Freeman D, Kaplan I, Fuller D, Bolzicco G, Collins S, Meier R, Wang J, Kupelian P, Steinberg M, Katz A. Stereotactic body radiotherapy for localized prostate cancer: pooled analysis from a multi-institutional consortium of prospective phase II trials. Radiother Oncol 2013, 109:217-221. 10.1016/j.radonc.2013.08.030, 24060175.
    • (2013) Radiother Oncol , vol.109 , pp. 217-221
    • King, C.R.1    Freeman, D.2    Kaplan, I.3    Fuller, D.4    Bolzicco, G.5    Collins, S.6    Meier, R.7    Wang, J.8    Kupelian, P.9    Steinberg, M.10    Katz, A.11
  • 2
    • 84888298095 scopus 로고    scopus 로고
    • Health-related quality of life after stereotactic body radiation therapy for localized prostate cancer: results from a multi-institutional consortium of prospective trials
    • 10.1016/j.ijrobp.2013.08.019, 24119836
    • King CR, Collins S, Fuller D, Wang PC, Kupelian P, Steinberg M, Katz A. Health-related quality of life after stereotactic body radiation therapy for localized prostate cancer: results from a multi-institutional consortium of prospective trials. Int J Radiat Oncol Biol Phys 2013, 87:939-945. 10.1016/j.ijrobp.2013.08.019, 24119836.
    • (2013) Int J Radiat Oncol Biol Phys , vol.87 , pp. 939-945
    • King, C.R.1    Collins, S.2    Fuller, D.3    Wang, P.C.4    Kupelian, P.5    Steinberg, M.6    Katz, A.7
  • 3
    • 49549093853 scopus 로고    scopus 로고
    • Intrafractional motion of the prostate during hypofractionated radiotherapy
    • 10.1016/j.ijrobp.2008.04.051, 2725181, 18722274
    • Xie Y, Djajaputra D, King CR, Hossain S, Ma L, Xing L. Intrafractional motion of the prostate during hypofractionated radiotherapy. Int J Radiat Oncol Biol Phys 2008, 72:236-246. 10.1016/j.ijrobp.2008.04.051, 2725181, 18722274.
    • (2008) Int J Radiat Oncol Biol Phys , vol.72 , pp. 236-246
    • Xie, Y.1    Djajaputra, D.2    King, C.R.3    Hossain, S.4    Ma, L.5    Xing, L.6
  • 4
    • 84873731661 scopus 로고    scopus 로고
    • Six-dimensional correction of intra-fractional prostate motion with CyberKnife stereotactic body radiation therapy
    • 3356099, 22655248
    • Lei S, Piel N, Oermann EK, Chen V, Ju AW, Dahal KN, Hanscom HN, Kim JS, Yu X, Zhang G, et al. Six-dimensional correction of intra-fractional prostate motion with CyberKnife stereotactic body radiation therapy. Front Oncol 2011, 1:48. 3356099, 22655248.
    • (2011) Front Oncol , vol.1 , pp. 48
    • Lei, S.1    Piel, N.2    Oermann, E.K.3    Chen, V.4    Ju, A.W.5    Dahal, K.N.6    Hanscom, H.N.7    Kim, J.S.8    Yu, X.9    Zhang, G.10
  • 5
    • 84877613382 scopus 로고    scopus 로고
    • Stereotactic body radiotherapy for localized prostate cancer: disease control and quality of life at 6 years
    • 10.1186/1748-717X-8-118, 3674983, 23668632
    • Katz AJ, Santoro M, Diblasio F, Ashley R. Stereotactic body radiotherapy for localized prostate cancer: disease control and quality of life at 6 years. Radiat Oncol 2013, 8:118. 10.1186/1748-717X-8-118, 3674983, 23668632.
    • (2013) Radiat Oncol , vol.8 , pp. 118
    • Katz, A.J.1    Santoro, M.2    Diblasio, F.3    Ashley, R.4
  • 6
    • 78650982500 scopus 로고    scopus 로고
    • Stereotactic body radiotherapy for low-risk prostate cancer: five-year outcomes
    • 10.1186/1748-717X-6-3, 3022740, 21219625
    • Freeman DE, King CR. Stereotactic body radiotherapy for low-risk prostate cancer: five-year outcomes. Radiat Oncol 2011, 6:3. 10.1186/1748-717X-6-3, 3022740, 21219625.
    • (2011) Radiat Oncol , vol.6 , pp. 3
    • Freeman, D.E.1    King, C.R.2
  • 7
    • 84874790786 scopus 로고    scopus 로고
    • Stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience
    • 10.1186/1748-717X-8-58, 3610192, 23497695
    • Chen LN, Suy S, Uhm S, Oermann EK, Ju AW, Chen V, Hanscom HN, Laing S, Kim JS, Lei S, et al. Stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience. Radiat Oncol 2013, 8:58. 10.1186/1748-717X-8-58, 3610192, 23497695.
    • (2013) Radiat Oncol , vol.8 , pp. 58
    • Chen, L.N.1    Suy, S.2    Uhm, S.3    Oermann, E.K.4    Ju, A.W.5    Chen, V.6    Hanscom, H.N.7    Laing, S.8    Kim, J.S.9    Lei, S.10
  • 8
    • 84864134449 scopus 로고    scopus 로고
    • Hypofractionated stereotactic body radiotherapy in low-risk prostate adenocarcinoma: preliminary results of a multi-institutional phase 1 feasibility trial
    • 10.1002/cncr.26699, 22170628
    • McBride SM, Wong DS, Dombrowski JJ, Harkins B, Tapella P, Hanscom HN, Collins SP, Kaplan ID. Hypofractionated stereotactic body radiotherapy in low-risk prostate adenocarcinoma: preliminary results of a multi-institutional phase 1 feasibility trial. Cancer 2012, 118:3681-3690. 10.1002/cncr.26699, 22170628.
    • (2012) Cancer , vol.118 , pp. 3681-3690
    • McBride, S.M.1    Wong, D.S.2    Dombrowski, J.J.3    Harkins, B.4    Tapella, P.5    Hanscom, H.N.6    Collins, S.P.7    Kaplan, I.D.8
  • 9
    • 0032538069 scopus 로고    scopus 로고
    • Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer
    • 10.1001/jama.280.11.969, 9749478
    • D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA, Tomaszewski JE, Renshaw AA, Kaplan I, Beard CJ, Wein A. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998, 280:969-974. 10.1001/jama.280.11.969, 9749478.
    • (1998) JAMA , vol.280 , pp. 969-974
    • D'Amico, A.V.1    Whittington, R.2    Malkowicz, S.B.3    Schultz, D.4    Blank, K.5    Broderick, G.A.6    Tomaszewski, J.E.7    Renshaw, A.A.8    Kaplan, I.9    Beard, C.J.10    Wein, A.11
  • 11
    • 34249026715 scopus 로고    scopus 로고
    • Quality of life after surgery, external beam irradiation, or brachytherapy for early-stage prostate cancer
    • 10.1002/cncr.22676, 17455209
    • Litwin MS, Gore JL, Kwan L, Brandeis JM, Lee SP, Withers HR, Reiter RE. Quality of life after surgery, external beam irradiation, or brachytherapy for early-stage prostate cancer. Cancer 2007, 109:2239-2247. 10.1002/cncr.22676, 17455209.
    • (2007) Cancer , vol.109 , pp. 2239-2247
    • Litwin, M.S.1    Gore, J.L.2    Kwan, L.3    Brandeis, J.M.4    Lee, S.P.5    Withers, H.R.6    Reiter, R.E.7
  • 12
    • 79958842451 scopus 로고    scopus 로고
    • Correlates of bother following treatment for clinically localized prostate cancer
    • 10.1016/j.juro.2010.06.012, 20723914
    • Gore JL, Gollapudi K, Bergman J, Kwan L, Krupski TL, Litwin MS. Correlates of bother following treatment for clinically localized prostate cancer. J Urol 2010, 184:1309-1315. 10.1016/j.juro.2010.06.012, 20723914.
    • (2010) J Urol , vol.184 , pp. 1309-1315
    • Gore, J.L.1    Gollapudi, K.2    Bergman, J.3    Kwan, L.4    Krupski, T.L.5    Litwin, M.S.6
  • 13
    • 77954893757 scopus 로고    scopus 로고
    • Sexual function after stereotactic body radiotherapy for prostate cancer: results of a prospective clinical trial
    • 10.1016/j.ijrobp.2009.07.1748, 20137864
    • Wiegner EA, King CR. Sexual function after stereotactic body radiotherapy for prostate cancer: results of a prospective clinical trial. Int J Radiat Oncol Biol Phys 2010, 78:442-448. 10.1016/j.ijrobp.2009.07.1748, 20137864.
    • (2010) Int J Radiat Oncol Biol Phys , vol.78 , pp. 442-448
    • Wiegner, E.A.1    King, C.R.2
  • 14
    • 33748936114 scopus 로고    scopus 로고
    • Should function and bother be measured and reported separately for prostate cancer quality-of-life domains?
    • 10.1016/j.urology.2006.03.037, 16979720
    • Reeve BB, Potosky AL, Willis GB. Should function and bother be measured and reported separately for prostate cancer quality-of-life domains?. Urology 2006, 68:599-603. 10.1016/j.urology.2006.03.037, 16979720.
    • (2006) Urology , vol.68 , pp. 599-603
    • Reeve, B.B.1    Potosky, A.L.2    Willis, G.B.3
  • 15
    • 84880772899 scopus 로고    scopus 로고
    • Sexual bother and function after radical prostatectomy: predictors of sexual bother recovery in men despite persistent post-operative sexual dysfunction
    • 10.1111/j.2047-2927.2012.00036.x, 23413138
    • Kimura M, Banez LL, Polascik TJ, Bernal RM, Gerber L, Robertson CN, Donatucci CF, Moul JW. Sexual bother and function after radical prostatectomy: predictors of sexual bother recovery in men despite persistent post-operative sexual dysfunction. Andrology 2013, 1:256-261. 10.1111/j.2047-2927.2012.00036.x, 23413138.
    • (2013) Andrology , vol.1 , pp. 256-261
    • Kimura, M.1    Banez, L.L.2    Polascik, T.J.3    Bernal, R.M.4    Gerber, L.5    Robertson, C.N.6    Donatucci, C.F.7    Moul, J.W.8
  • 16
    • 79952248754 scopus 로고    scopus 로고
    • To what extent can response shift theory explain the variation in prostate cancer patients' reactions to treatment side-effects? A review
    • 10.1007/s11136-010-9745-y, 20890663
    • Donohoe JE. To what extent can response shift theory explain the variation in prostate cancer patients' reactions to treatment side-effects? A review. Qual Life Res 2011, 20:161-167. 10.1007/s11136-010-9745-y, 20890663.
    • (2011) Qual Life Res , vol.20 , pp. 161-167
    • Donohoe, J.E.1
  • 17
    • 34247618655 scopus 로고    scopus 로고
    • Education predicts quality of life among men with prostate cancer cared for in the Department of Veterans Affairs: a longitudinal quality of life analysis from CaPSURE
    • 10.1002/cncr.22597, 17380491
    • Knight SJ, Latini DM, Hart SL, Sadetsky N, Kane CJ, DuChane J, Carroll PR. Education predicts quality of life among men with prostate cancer cared for in the Department of Veterans Affairs: a longitudinal quality of life analysis from CaPSURE. Cancer 2007, 109:1769-1776. 10.1002/cncr.22597, 17380491.
    • (2007) Cancer , vol.109 , pp. 1769-1776
    • Knight, S.J.1    Latini, D.M.2    Hart, S.L.3    Sadetsky, N.4    Kane, C.J.5    DuChane, J.6    Carroll, P.R.7
  • 18
    • 84892438488 scopus 로고    scopus 로고
    • Patient preference and the impact of decision-making aids on prostate cancer treatment choices and post-intervention regret
    • 3553561, 23355792
    • Aning JJ, Wassersug RJ, Goldenberg SL. Patient preference and the impact of decision-making aids on prostate cancer treatment choices and post-intervention regret. Curr Oncol 2012, 19:S37-S44. 3553561, 23355792.
    • (2012) Curr Oncol , vol.19
    • Aning, J.J.1    Wassersug, R.J.2    Goldenberg, S.L.3
  • 19
    • 84888644807 scopus 로고    scopus 로고
    • Neoadjuvant androgen deprivation therapy leads to immediate impairment of vitality/hormonal and sexual quality of life: results of a msulticenter prospective study
    • 10.1016/j.urology.2013.06.062, 24139340
    • Gay HA, Michalski JM, Hamstra DA, Wei JT, Dunn RL, Klein EA, Sandler HM, Saigal C, Litwin M, Kuban D, et al. Neoadjuvant androgen deprivation therapy leads to immediate impairment of vitality/hormonal and sexual quality of life: results of a msulticenter prospective study. Urology 2013, 82:1363-1369. 10.1016/j.urology.2013.06.062, 24139340.
    • (2013) Urology , vol.82 , pp. 1363-1369
    • Gay, H.A.1    Michalski, J.M.2    Hamstra, D.A.3    Wei, J.T.4    Dunn, R.L.5    Klein, E.A.6    Sandler, H.M.7    Saigal, C.8    Litwin, M.9    Kuban, D.10
  • 20
    • 0033669409 scopus 로고    scopus 로고
    • Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer
    • 10.1016/S0090-4295(00)00858-X, 11113727
    • Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology 2000, 56:899-905. 10.1016/S0090-4295(00)00858-X, 11113727.
    • (2000) Urology , vol.56 , pp. 899-905
    • Wei, J.T.1    Dunn, R.L.2    Litwin, M.S.3    Sandler, H.M.4    Sanda, M.G.5
  • 21
    • 0026591918 scopus 로고
    • The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association
    • discussion 1564
    • Barry MJ, Fowler FJ, O'Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, Cockett AT. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol 1992, 148:1549-1557. discussion 1564.
    • (1992) J Urol , vol.148 , pp. 1549-1557
    • Barry, M.J.1    Fowler, F.J.2    O'Leary, M.P.3    Bruskewitz, R.C.4    Holtgrewe, H.L.5    Mebust, W.K.6    Cockett, A.T.7
  • 22
    • 0036668536 scopus 로고    scopus 로고
    • The International Index of Erectile Function (IIEF): a state-of-the-science review
    • 10.1038/sj.ijir.3900857, 12152111
    • Rosen RC, Cappelleri JC, Gendrano N. The International Index of Erectile Function (IIEF): a state-of-the-science review. Int J Impot Res 2002, 14:226-244. 10.1038/sj.ijir.3900857, 12152111.
    • (2002) Int J Impot Res , vol.14 , pp. 226-244
    • Rosen, R.C.1    Cappelleri, J.C.2    Gendrano, N.3
  • 23
    • 0037980149 scopus 로고    scopus 로고
    • Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation
    • Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 2003, 41:582-592.
    • (2003) Med Care , vol.41 , pp. 582-592
    • Norman, G.R.1    Sloan, J.A.2    Wyrwich, K.W.3
  • 24
    • 36749054178 scopus 로고    scopus 로고
    • Long-term urinary sequelae following 125iodine prostate brachytherapy
    • discussion 146
    • Crook J, Fleshner N, Roberts C, Pond G. Long-term urinary sequelae following 125iodine prostate brachytherapy. J Urol 2008, 179:141-145. discussion 146.
    • (2008) J Urol , vol.179 , pp. 141-145
    • Crook, J.1    Fleshner, N.2    Roberts, C.3    Pond, G.4
  • 27
    • 0038724750 scopus 로고    scopus 로고
    • Urinary symptom flare following I-125 prostate brachytherapy
    • 10.1016/S0360-3016(03)00210-4, 12829146
    • Cesaretti JA, Stone NN, Stock RG. Urinary symptom flare following I-125 prostate brachytherapy. Int J Radiat Oncol Biol Phys 2003, 56:1085-1092. 10.1016/S0360-3016(03)00210-4, 12829146.
    • (2003) Int J Radiat Oncol Biol Phys , vol.56 , pp. 1085-1092
    • Cesaretti, J.A.1    Stone, N.N.2    Stock, R.G.3
  • 28
    • 84880582318 scopus 로고    scopus 로고
    • Multi-institutional prospective evaluation of bowel quality of life after prostate external beam radiation therapy identifies patient and treatment factors associated with patient-reported outcomes: the PROSTQA experience
    • 10.1016/j.ijrobp.2013.01.036, 23561651
    • Hamstra DA, Conlon AS, Daignault S, Dunn RL, Sandler HM, Hembroff AL, Zietman AL, Kaplan I, Ciezki J, Kuban DA, et al. Multi-institutional prospective evaluation of bowel quality of life after prostate external beam radiation therapy identifies patient and treatment factors associated with patient-reported outcomes: the PROSTQA experience. Int J Radiat Oncol Biol Phys 2013, 86:546-553. 10.1016/j.ijrobp.2013.01.036, 23561651.
    • (2013) Int J Radiat Oncol Biol Phys , vol.86 , pp. 546-553
    • Hamstra, D.A.1    Conlon, A.S.2    Daignault, S.3    Dunn, R.L.4    Sandler, H.M.5    Hembroff, A.L.6    Zietman, A.L.7    Kaplan, I.8    Ciezki, J.9    Kuban, D.A.10
  • 29
    • 84885480907 scopus 로고    scopus 로고
    • New developments in the diagnosis and treatment of chronic prostatitis/chronic pelvic pain syndrome
    • 10.1097/MOU.0b013e3283656a55, 24080807
    • Pontari M, Giusto L. New developments in the diagnosis and treatment of chronic prostatitis/chronic pelvic pain syndrome. Curr Opin Urol 2013, 23:565-569. 10.1097/MOU.0b013e3283656a55, 24080807.
    • (2013) Curr Opin Urol , vol.23 , pp. 565-569
    • Pontari, M.1    Giusto, L.2
  • 30
    • 68049123415 scopus 로고    scopus 로고
    • Sequence variant discovery in DNA repair genes from radiosensitive and radiotolerant prostate brachytherapy patients
    • 10.1158/1078-0432.CCR-08-3357, 19638463
    • Pugh TJ, Keyes M, Barclay L, Delaney A, Krzywinski M, Thomas D, Novik K, Yang C, Agranovich A, McKenzie M, et al. Sequence variant discovery in DNA repair genes from radiosensitive and radiotolerant prostate brachytherapy patients. Clin Cancer Res 2009, 15:5008-5016. 10.1158/1078-0432.CCR-08-3357, 19638463.
    • (2009) Clin Cancer Res , vol.15 , pp. 5008-5016
    • Pugh, T.J.1    Keyes, M.2    Barclay, L.3    Delaney, A.4    Krzywinski, M.5    Thomas, D.6    Novik, K.7    Yang, C.8    Agranovich, A.9    McKenzie, M.10
  • 31
    • 84860323201 scopus 로고    scopus 로고
    • Among potent men post radical prostatectomy, does the need for phosphodiesterase inhibitors have an impact on sexual bother scores?
    • 10.1111/j.1464-410X.2011.10605.x, 3288727, 21999368
    • Punnen S, Cooperberg MR, Sadetsky N, Carroll PR. Among potent men post radical prostatectomy, does the need for phosphodiesterase inhibitors have an impact on sexual bother scores?. BJU Int 2012, 109:1520-1524. 10.1111/j.1464-410X.2011.10605.x, 3288727, 21999368.
    • (2012) BJU Int , vol.109 , pp. 1520-1524
    • Punnen, S.1    Cooperberg, M.R.2    Sadetsky, N.3    Carroll, P.R.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.